Insider Transactions by Schobel Alexander Mark

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerMar 15, 2024Sale$6.0050,000300,000984,476Mar 19, 2024, 02:30 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerMar 08, 2024Sale$5.1925,000129,6851,040,371Mar 12, 2024, 01:45 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerMar 09, 2024Option Exercise$4.885,89528,7681,034,476Mar 12, 2024, 01:45 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerJun 08, 2022Buy$0.9645,87144,036882,871Jun 10, 2022, 05:26 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerFeb 09, 2021Sale$6.7511,54077,895860,460Feb 10, 2021, 08:17 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerFeb 10, 2021Sale$6.7523,460158,355837,000Feb 10, 2021, 08:17 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerFeb 08, 2021Sale$6.5040,792265,148872,000Feb 09, 2021, 04:00 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerJun 30, 2020Option Exercise$4.8694457912,792Jul 02, 2020, 12:00 AM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerMay 31, 2020Option Exercise$4.874,13220,123912,553Jun 02, 2020, 05:14 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerMay 08, 2020Sale$5.0040,000200,000902,113May 11, 2020, 04:15 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerApr 14, 2020Sale$3.7040,000148,000982,113May 04, 2020, 04:05 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerApr 27, 2020Sale$4.0040,000160,000942,113May 04, 2020, 04:05 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerApr 29, 2020Sale$4.5040,000180,0001,022,113May 01, 2020, 04:05 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerMar 31, 2020Option Exercise$2.19972121,062,113Apr 02, 2020, 04:16 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerFeb 29, 2020Option Exercise$3.735,06618,8961,061,881Mar 03, 2020, 07:38 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerDec 31, 2019Option Exercise$5.821478561,052,375Feb 26, 2020, 04:20 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerNov 30, 2019Option Exercise$7.796,54450,9781,052,193Feb 26, 2020, 04:05 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerDec 31, 2019Option Exercise$5.823291,9151,044,165Jan 02, 2020, 04:15 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerNov 30, 2019Option Exercise$7.7914,572113,5161,044,165Dec 02, 2019, 04:56 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerSep 30, 2019Option Exercise$3.181454611,044,165Oct 02, 2019, 04:33 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerAug 31, 2019Option Exercise$3.806,46024,5481,043,981Sep 03, 2019, 06:09 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerJun 30, 2019Option Exercise$4.201496261,035,869Jul 02, 2019, 12:00 AM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerMay 31, 2019Option Exercise$3.726,59124,5191,035,689Jun 03, 2019, 04:15 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerMar 31, 2019Option Exercise$6.912631,8171,027,708Apr 01, 2019, 04:40 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerFeb 28, 2019Option Exercise$8.056,72154,1041,027,642Mar 01, 2019, 05:23 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerDec 31, 2018Option Exercise$6.301621,0211,019,791Jan 03, 2019, 05:30 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerDec 10, 2018Buy$7.781,0007,7801,019,624Dec 11, 2018, 05:41 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerDec 06, 2018Buy$8.692,00017,3801,018,624Dec 10, 2018, 05:47 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerNov 30, 2018Option Exercise$8.597,17761,6501,016,624Dec 04, 2018, 04:05 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerNov 21, 2018Buy$10.251,00010,2501,009,229Nov 26, 2018, 01:43 PM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerSep 30, 2018Option Exercise$17.511622,8371,008,229Oct 02, 2018, 12:00 AM
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech OfficerAug 31, 2018Option Exercise$18.016,510117,2451,008,062Sep 05, 2018, 05:39 PM